Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 10 de 10
Filtrar
1.
BMJ Case Rep ; 12(5)2019 May 14.
Artículo en Inglés | MEDLINE | ID: mdl-31092494

RESUMEN

Erythema multiforme is a skin disorder characterised by target epithelial eruption, which is mainly caused by infection or drugs. In this case, we report an erythema multiforme like reaction caused by contact dermatitis against wood, especially santos rosewood. During the hospitalisation, we performed a patch test with lumber used in the patient's workplace, and recognised a positive response to multiple woods and a simultaneous recurring eruption (flare up) outside of the test site. The findings from this case of contact dermatitis caused by frequently used industrial wood type is important for the management of occupational environments. A review of the literature on erythema multiforme like reaction due to contact dermatitis, including past case reports, has also been provided.


Asunto(s)
Eritema Multiforme/etiología , Enfermedades Profesionales/etiología , Madera/efectos adversos , Administración Cutánea , Adulto , Clobetasol/administración & dosificación , Dermatitis Alérgica por Contacto , Eritema Multiforme/diagnóstico , Eritema Multiforme/tratamiento farmacológico , Fabaceae/efectos adversos , Humanos , Masculino , Enfermedades Profesionales/diagnóstico , Enfermedades Profesionales/tratamiento farmacológico , Pruebas del Parche , Taxaceae/efectos adversos
2.
Ann Hepatol ; 18(5): 777-779, 2019.
Artículo en Inglés | MEDLINE | ID: mdl-31085038

RESUMEN

A 63-year-old female patient with recent diagnosis of hepatitis C and cirrhosis and no other comorbidities, on no medications, was found to have Barcelona Clinic Liver Cancer stage C hepatocellular carcinoma and began systemic therapy with sorafenib 400mg twice daily. Five days after starting treatment, the patient went to an emergency department with pruritic, target-shaped, erythematous papules compatible with erythema multiforme, painful oral aphthous ulcers, and fever. Sorafenib was suspended and the patient underwent oral corticosteroid treatment for 5 days, showing significant improvement of the lesions. One month after discharge, the patient was reassessed at an outpatient clinic. As she was asymptomatic and had no skin lesions, sorafenib was resumed at a lower dose (200mg daily). Three hours after ingesting a single dose of sorafenib, the patient experienced chills, fever, rash, angioedema and stridor. She immediately sought the emergency department and was diagnosed with anaphylaxis. The patient received intravenous corticosteroid therapy, which improved her respiratory and cutaneous symptoms in 72h. Sorafenib was permanently suspended, and regorafenib could not be prescribed as second-line therapy. This is the first description of anaphylaxis to sorafenib.


Asunto(s)
Anafilaxia/inducido químicamente , Eritema Multiforme/inducido químicamente , Prednisona/uso terapéutico , Sorafenib/efectos adversos , Anafilaxia/tratamiento farmacológico , Antineoplásicos/efectos adversos , Antineoplásicos/uso terapéutico , Carcinoma Hepatocelular/complicaciones , Carcinoma Hepatocelular/tratamiento farmacológico , Eritema Multiforme/tratamiento farmacológico , Femenino , Glucocorticoides/uso terapéutico , Humanos , Cirrosis Hepática/complicaciones , Neoplasias Hepáticas/complicaciones , Neoplasias Hepáticas/tratamiento farmacológico , Persona de Mediana Edad , Sorafenib/uso terapéutico
4.
Nihon Shokakibyo Gakkai Zasshi ; 111(7): 1424-32, 2014 Jul.
Artículo en Japonés | MEDLINE | ID: mdl-24998734

RESUMEN

Erythema multiforme (EM) is a known side effect of sorafenib therapy in cancer patients; at onset, the causative medication should be permanently discontinued. Here we report two cases of hepatocellular carcinoma (HCC) that developed sorafenib-induced EM. In both cases, retreatment with sorafenib combined with steroid therapy achieved effective tumor control without EM recurrence. The first patient was a 72-year-old woman who showed a dramatic response to sorafenib retreatment, with complete remission after 8 months of therapy. There was no rash recurrence after the steroid dose was gradually tapered and stopped. The second patient was a 69-year-old man who responded to sorafenib and exhibited stable disease, with no recurrence of the rash after the steroid dose was tapered. However, mild hand-foot syndrome persisted throughout sorafenib therapy. Although sorafenib should be discontinued if EM occurs, if there is no suitable alternative treatment, retreatment may be considered with steroid cover in patients with unresectable HCC.


Asunto(s)
Antineoplásicos/efectos adversos , Carcinoma Hepatocelular/tratamiento farmacológico , Eritema Multiforme/inducido químicamente , Eritema Multiforme/tratamiento farmacológico , Neoplasias Hepáticas/tratamiento farmacológico , Niacinamida/análogos & derivados , Compuestos de Fenilurea/efectos adversos , Prednisolona/administración & dosificación , Anciano , Antineoplásicos/administración & dosificación , Carcinoma Hepatocelular/complicaciones , Femenino , Humanos , Neoplasias Hepáticas/complicaciones , Masculino , Niacinamida/administración & dosificación , Niacinamida/efectos adversos , Compuestos de Fenilurea/administración & dosificación , Sorafenib
5.
Zhongguo Zhen Jiu ; 29(10): 807-9, 2009 Oct.
Artículo en Chino | MEDLINE | ID: mdl-19873917

RESUMEN

OBJECTIVE: To search for an effective therapy for cold erythema multiforme in ham. METHODS: One hundred and eighty cases with cold erythema multiforme in ham were randomly divided into a Santong group (n=90) and a western medicine group (n=90). The Santong group was treated by He's Santong needling methods and Huantiao (GB 30), Fengshi (GB 31), Zusanli (ST 36), etc. were selected. The western medicine group was treated by oral administration of Cinnarizine, Cyproheptadine and Vitamin E. Two weeks later, their therapeutic effects were observed. RESULTS: The cured rate was 68.9% and the recurrence rate was 11.3% in the Santong group, and 33.3% and 53.3% in the western medicine group, with significant differences in the cured rate and the recurrence rate between the two groups (both P<0.01). CONCLUSION: He's Santong needling methods can increase the cured rate and reduce the recurrence rate of cold erythema multiforme in ham.


Asunto(s)
Terapia por Acupuntura , Eritema Multiforme/terapia , Adolescente , Adulto , Cinarizina/uso terapéutico , Ciproheptadina/uso terapéutico , Eritema Multiforme/tratamiento farmacológico , Femenino , Antagonistas de los Receptores Histamínicos H1/uso terapéutico , Humanos , Masculino , Resultado del Tratamiento , Adulto Joven
6.
In. Prabhu, S. R. Textbook of oral medicine. New York, Oxford University Press, 2004. p.190-206, tab.
Monografía en Inglés | MedCarib | ID: med-16954
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA